NO995846L - Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitet - Google Patents
Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitetInfo
- Publication number
- NO995846L NO995846L NO995846A NO995846A NO995846L NO 995846 L NO995846 L NO 995846L NO 995846 A NO995846 A NO 995846A NO 995846 A NO995846 A NO 995846A NO 995846 L NO995846 L NO 995846L
- Authority
- NO
- Norway
- Prior art keywords
- antibacterial agents
- oxazolidinone antibacterial
- thiocarbonyl functionality
- thiocarbonyl
- functionality
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4834297P | 1997-05-30 | 1997-05-30 | |
PCT/US1998/009889 WO1998054161A1 (en) | 1997-05-30 | 1998-05-18 | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
Publications (3)
Publication Number | Publication Date |
---|---|
NO995846D0 NO995846D0 (no) | 1999-11-29 |
NO995846L true NO995846L (no) | 2000-01-28 |
NO315798B1 NO315798B1 (no) | 2003-10-27 |
Family
ID=21954059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19995846A NO315798B1 (no) | 1997-05-30 | 1999-11-29 | Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitet |
Country Status (20)
Country | Link |
---|---|
US (1) | US6218413B1 (no) |
EP (1) | EP0984947B8 (no) |
JP (1) | JP2002501530A (no) |
KR (1) | KR20010013192A (no) |
CN (1) | CN1138765C (no) |
AT (1) | ATE293609T1 (no) |
AU (1) | AU737995B2 (no) |
BR (1) | BR9815518A (no) |
CA (1) | CA2288750A1 (no) |
DE (1) | DE69829846T2 (no) |
ES (1) | ES2242280T3 (no) |
FI (1) | FI19992555A (no) |
HK (1) | HK1027569A1 (no) |
HU (1) | HUP0001393A3 (no) |
NO (1) | NO315798B1 (no) |
NZ (1) | NZ501412A (no) |
PL (1) | PL337329A1 (no) |
RU (1) | RU2208613C2 (no) |
SK (1) | SK156499A3 (no) |
WO (1) | WO1998054161A1 (no) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100463772B1 (ko) * | 1995-09-01 | 2005-11-09 | 파마시아 앤드 업존 캄파니 엘엘씨 | 4내지8원헤테로사이클릭환에탄소-탄소결합을갖는페닐옥사졸리디논 |
CA2315735A1 (en) * | 1998-02-13 | 1999-08-19 | Michael R. Barbachyn | Substituted aminophenyl isoxazoline derivatives useful as antimicrobials |
WO1999043671A1 (en) * | 1998-02-25 | 1999-09-02 | Pharmacia & Upjohn Company | Substituted aminomethyl isoxazoline derivatives useful as antimicrobials |
CN1311787A (zh) | 1998-06-05 | 2001-09-05 | 阿斯特拉曾尼卡有限公司 | 噁唑烷酮衍生物、其制备方法以及含有它们的药物组合物 |
JP2000204084A (ja) * | 1998-11-11 | 2000-07-25 | Hokuriku Seiyaku Co Ltd | チオカルバミド酸誘導体 |
WO2000029396A1 (de) * | 1998-11-17 | 2000-05-25 | Bayer Aktiengesellschaft | Neue substituierte phenyloxazolidon-derivate |
AU1045300A (en) * | 1998-11-17 | 2000-06-05 | Bayer Aktiengesellschaft | Novel heterocyclyl-substituted oxazolidone derivatives |
CA2351062A1 (en) * | 1998-11-27 | 2000-06-08 | Pharmacia & Upjohn Company | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
MXPA02000985A (es) * | 1999-07-28 | 2002-07-30 | Upjohn Co | Oxazolidinonas y su uso como antiinfecciosos. |
US6413981B1 (en) | 1999-08-12 | 2002-07-02 | Ortho-Mcneil Pharamceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
US6297242B1 (en) * | 1999-08-12 | 2001-10-02 | Ortho-Mcneil Pharmaceutical, Inc. | N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof |
US6608081B2 (en) | 1999-08-12 | 2003-08-19 | Ortho-Mcneil Pharmaceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
MY120189A (en) | 1999-11-04 | 2005-09-30 | Upjohn Co | Sultam and sultone derived oxazolidinones |
GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
PE20010851A1 (es) * | 1999-12-14 | 2001-08-17 | Upjohn Co | Esteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina |
CN1221548C (zh) * | 1999-12-21 | 2005-10-05 | 法玛西雅厄普约翰美国公司 | 含有砜亚氨基官能团的噁唑烷酮 |
US6518285B2 (en) | 1999-12-21 | 2003-02-11 | Ortho Mcneil Pharmaceutical, Inc. | Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials |
DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
US6642238B2 (en) * | 2000-02-10 | 2003-11-04 | Pharmacia And Upjohn Company | Oxazolidinone thioamides with piperazine amide substituents |
NZ520696A (en) * | 2000-02-10 | 2004-03-26 | Upjohn Co | Piperazine amide substituted oxazolidinone thioamides useful for treating bacteria infections |
AU2001253113B2 (en) * | 2000-04-20 | 2005-02-03 | Pharmacia & Upjohn Company | Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis |
GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
US6562820B2 (en) | 2000-07-05 | 2003-05-13 | Pharmacia & Upjohn Company | Method for treatment and prevention of mastitis |
PL363960A1 (en) * | 2000-07-17 | 2004-11-29 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
PE20020689A1 (es) * | 2000-11-17 | 2002-08-03 | Upjohn Co | Oxazolidinonas con un heterociclo de 6 o 7 miembros unidos con enlace anular al benceno |
CN1250544C (zh) | 2001-02-07 | 2006-04-12 | 奥索-麦克尼尔药品公司 | 吡啶并芳基苯基噁唑烷酮抗菌剂和相关组合物及方法 |
DE60212959T2 (de) * | 2001-04-07 | 2007-02-15 | Astrazeneca Ab | Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika |
DE10129725A1 (de) | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
AR038536A1 (es) | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
US7141588B2 (en) | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
MXPA05001199A (es) * | 2002-07-29 | 2005-05-16 | Ranbaxy Lab Ltd | Derivados de oxazolidinona como antimicrobianos. |
US7094900B2 (en) | 2002-08-12 | 2006-08-22 | Pharmacia & Upjohn Company Llc | N-Aryl-2-oxazolidinones and their derivatives |
US6875784B2 (en) | 2002-10-09 | 2005-04-05 | Pharmacia & Upjohn Company | Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives |
US7105547B2 (en) | 2002-10-10 | 2006-09-12 | Pharmacia And Upjohn Company | Antimicrobial 1-aryl dihydropyridone compounds |
EP1565186B1 (en) | 2002-11-21 | 2006-11-02 | Pharmacia & Upjohn Company LLC | N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents |
GB0229521D0 (en) * | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
DE10300111A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
JP2006522791A (ja) | 2003-04-09 | 2006-10-05 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 抗微生物性[3.1.0]ビシクロヘキシルフェニルオキサゾリジノン誘導体および類似体 |
US8324398B2 (en) | 2003-06-03 | 2012-12-04 | Rib-X Pharmaceuticals, Inc. | Process for the synthesis of biaryl oxazolidinones |
EP2492264A3 (en) | 2003-06-03 | 2012-12-19 | Rib-X Pharmaceuticals, Inc. | Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same |
EP1660488A1 (en) * | 2003-08-25 | 2006-05-31 | Warner-Lambert Company LLC | Novel antimicrobial aryloxazolidinone compounds |
US7687627B2 (en) * | 2003-09-08 | 2010-03-30 | Wockhardt Limited | Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy |
US7304050B2 (en) | 2003-09-16 | 2007-12-04 | Pfizer Inc. | Antibacterial agents |
DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
TW200526649A (en) * | 2003-12-17 | 2005-08-16 | Rib X Pharmaceuticals Inc | Halogenated biaryl heterocyclic compounds and methods of making and using the same |
WO2005082900A2 (en) * | 2004-01-28 | 2005-09-09 | Pharmacia & Upjohn Company Llc | Oxazolidinone amidoximes as antibacterial agents |
DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
EP1685841A1 (en) | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention and treatment of thromboembolic disorders |
WO2006109156A1 (en) | 2005-04-15 | 2006-10-19 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
JP5534497B2 (ja) | 2005-06-08 | 2014-07-02 | メリンタ セラピューティクス,インコーポレイテッド | トリアゾール類の合成方法 |
DE102005045518A1 (de) | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
DE102005047558A1 (de) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen |
DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
CA2823159C (en) | 2005-10-04 | 2014-10-21 | Bayer Intellectual Property Gmbh | Polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide |
WO2007114326A1 (ja) | 2006-03-31 | 2007-10-11 | Research Foundation Itsuu Laboratory | ヘテロ環を有する新規化合物 |
CA2692255A1 (en) * | 2007-06-22 | 2008-12-31 | Orchid Research Laboratories Limited | Novel compounds and their use |
EP2208729A4 (en) | 2007-10-02 | 2011-04-27 | Res Found Itsuu Lab | OXAZOLIDINONE DERIVATIVE WITH 7-CHAIN HETEROCYCLE |
CA2822357A1 (en) | 2010-12-22 | 2012-06-28 | Abbvie Inc. | Hepatitis c inhibitors and uses thereof |
WO2013054275A1 (en) * | 2011-10-11 | 2013-04-18 | Council Of Scientific & Industrial Research | Sila analogs of oxazolidinone derivatives and synthesis thereof |
CN103360294B (zh) * | 2012-03-28 | 2015-11-25 | 复旦大学 | 具有抗结核活性的化合物及其制备方法和应用 |
CN103044341B (zh) * | 2012-12-20 | 2015-07-01 | 郑州大学 | 1,2,3-三唑-氨基二硫代甲酸酯-脲复合体、其制备方法及其应用 |
WO2015031036A1 (en) * | 2013-08-26 | 2015-03-05 | Purdue Pharma L.P. | Azaspiro[4.5] decane derivatives and use thereof |
CN108299329A (zh) * | 2018-03-28 | 2018-07-20 | 许传森 | 一种噁唑酮类衍生物及其在抗菌药物中的应用 |
CN115466253B (zh) * | 2021-06-16 | 2024-08-20 | 沈阳药科大学 | 含二硫代氨基甲酸酯结构的噁唑烷酮类化合物及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES8506659A1 (es) | 1983-06-07 | 1985-08-01 | Du Pont | Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno. |
CA1260948A (en) * | 1984-12-05 | 1989-09-26 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents |
US4948801A (en) | 1988-07-29 | 1990-08-14 | E. I. Du Pont De Nemours And Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
ATE201870T1 (de) * | 1988-09-15 | 2001-06-15 | Upjohn Co | 3-(stickstoff substituierte)phenyl-5-beta- amidomethyloxazoliden-2-one |
MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
DE4425612A1 (de) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
GB9521508D0 (en) * | 1995-10-20 | 1995-12-20 | Zeneca Ltd | Chemical compounds |
DE19601264A1 (de) * | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone |
DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
ES2186916T3 (es) | 1996-08-21 | 2003-05-16 | Upjohn Co | Derivados de isoxazolina como agentes antimicrobianos. |
-
1998
- 1998-05-18 JP JP50072299A patent/JP2002501530A/ja not_active Withdrawn
- 1998-05-18 EP EP98922303A patent/EP0984947B8/en not_active Expired - Lifetime
- 1998-05-18 CN CNB98805423XA patent/CN1138765C/zh not_active Expired - Fee Related
- 1998-05-18 RU RU99128083/04A patent/RU2208613C2/ru not_active IP Right Cessation
- 1998-05-18 AU AU74883/98A patent/AU737995B2/en not_active Ceased
- 1998-05-18 AT AT98922303T patent/ATE293609T1/de not_active IP Right Cessation
- 1998-05-18 NZ NZ501412A patent/NZ501412A/en unknown
- 1998-05-18 CA CA002288750A patent/CA2288750A1/en not_active Abandoned
- 1998-05-18 SK SK1564-99A patent/SK156499A3/sk unknown
- 1998-05-18 WO PCT/US1998/009889 patent/WO1998054161A1/en not_active Application Discontinuation
- 1998-05-18 BR BR9815518-0A patent/BR9815518A/pt not_active Application Discontinuation
- 1998-05-18 HU HU0001393A patent/HUP0001393A3/hu unknown
- 1998-05-18 US US09/080,751 patent/US6218413B1/en not_active Expired - Fee Related
- 1998-05-18 KR KR19997011178A patent/KR20010013192A/ko active IP Right Grant
- 1998-05-18 PL PL98337329A patent/PL337329A1/xx unknown
- 1998-05-18 DE DE69829846T patent/DE69829846T2/de not_active Expired - Fee Related
- 1998-05-18 ES ES98922303T patent/ES2242280T3/es not_active Expired - Lifetime
-
1999
- 1999-11-29 NO NO19995846A patent/NO315798B1/no unknown
- 1999-11-30 FI FI992555A patent/FI19992555A/fi not_active IP Right Cessation
-
2000
- 2000-10-23 HK HK00106696A patent/HK1027569A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN1257486A (zh) | 2000-06-21 |
SK156499A3 (en) | 2000-06-12 |
WO1998054161A1 (en) | 1998-12-03 |
US6218413B1 (en) | 2001-04-17 |
NZ501412A (en) | 2001-11-30 |
KR20010013192A (ko) | 2001-02-26 |
JP2002501530A (ja) | 2002-01-15 |
HUP0001393A3 (en) | 2001-07-30 |
NO315798B1 (no) | 2003-10-27 |
ES2242280T3 (es) | 2005-11-01 |
BR9815518A (pt) | 2000-11-21 |
AU737995B2 (en) | 2001-09-06 |
EP0984947B8 (en) | 2005-06-15 |
HK1027569A1 (en) | 2001-01-19 |
PL337329A1 (en) | 2000-08-14 |
NO995846D0 (no) | 1999-11-29 |
AU7488398A (en) | 1998-12-30 |
EP0984947B1 (en) | 2005-04-20 |
EP0984947A1 (en) | 2000-03-15 |
FI19992555A (fi) | 1999-11-30 |
WO1998054161A9 (en) | 1999-04-08 |
CA2288750A1 (en) | 1998-12-03 |
CN1138765C (zh) | 2004-02-18 |
DE69829846T2 (de) | 2006-02-23 |
DE69829846D1 (de) | 2005-05-25 |
HUP0001393A2 (hu) | 2001-06-28 |
RU2208613C2 (ru) | 2003-07-20 |
ATE293609T1 (de) | 2005-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO995846D0 (no) | Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitet | |
DK0920421T3 (da) | Isoxazolinderivater anvendelige som antimikrobielle midler | |
PT1413582E (pt) | Pirrolobenzodiazepinas dimericas | |
BR9916798A (pt) | 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek | |
BR9914221B1 (pt) | Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos | |
DE69420564D1 (de) | Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)-homoserinlacton | |
UY26551A1 (es) | " agentes antibacterianos de 3-aminoquinazolin-2,4,dionas". | |
TR200100075T2 (tr) | 2-Kuinolon ihtiva eden farmasötik bileşimler | |
NO20062629L (no) | Oksazolderivater av tetrackliner | |
ES2195397T3 (es) | Quinazolin-2,4-dionas sustituidas en posicion 7 utiles como agentes antibacterianos. | |
DK1042319T3 (da) | Dihydrobenzofuraner | |
MY136297A (en) | Piperazine derivatives having sst1 antagonistic activity | |
DK1073447T3 (da) | N1-modificerede glycopeptider | |
DE60017374D1 (de) | Antibakterielle mittel | |
AR027349A1 (es) | Derivados de amidas heterociclicas | |
MXPA05009243A (es) | N-aril-2-oxazolidinona-5-carboxamidas y sus derivados. | |
PL373989A1 (en) | Novel benzonaphthyridines | |
BR0014303A (pt) | Sultam e sultona derivados de oxazolidinonas | |
MY123217A (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same | |
ECSP972237A (es) | Derivados de 6,5 heterobiciclicos sustituidos |